Mystic Asset Management Inc. Makes New $3.14 Million Investment in CVS Health Corporation $CVS

Mystic Asset Management Inc. purchased a new stake in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, Holdings Channel.com reports. The fund purchased 30,357 shares of the pharmacy operator’s stock, valued at approximately $3,140,000.

Other hedge funds have also made changes to their positions in the company. BlackRock Inc. purchased a new position in CVS Health during the second quarter worth about $12,747,462,000. Vanguard Group Inc. increased its stake in shares of CVS Health by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 120,709,530 shares of the pharmacy operator’s stock valued at $9,579,508,000 after acquiring an additional 1,824,424 shares during the last quarter. State Street Corp lifted its holdings in shares of CVS Health by 2.1% during the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares during the period. Capital International Investors boosted its position in shares of CVS Health by 3.4% in the fourth quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock worth $2,189,793,000 after acquiring an additional 900,153 shares during the last quarter. Finally, Norges Bank purchased a new stake in CVS Health in the fourth quarter valued at approximately $1,666,265,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS Health stock opened at $93.83 on Friday. The firm has a market capitalization of $120.01 billion, a PE ratio of 24.82, a price-to-earnings-growth ratio of 0.89 and a beta of 0.61. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The stock’s 50 day moving average price is $102.19 and its 200 day moving average price is $88.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the company earned $1.81 earnings per share. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, sell-side analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s payout ratio is 70.37%.

Wall Street Analyst Weigh In

CVS has been the subject of several research analyst reports. Wall Street Zen raised shares of CVS Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. JPMorgan Chase & Co. upped their price objective on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Robert W. Baird set a $107.00 target price on CVS Health in a research report on Thursday, August 6th. Wells Fargo & Company lifted their target price on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Finally, Sanford C. Bernstein upped their price target on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 12th. Twenty-two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.